Not everyone with type 2 diabetes is overweight, but obesity and an inactive lifestyle are two of the most common causes of type 2 diabetes. These factors are responsible for 90 to 95% of diabetes cases in the United States. There is no cure for type 2 diabetes. Losing weight, eating well and exercising can help control the disease. If diet and exercise aren't enough to control blood sugar, diabetes medications or insulin therapy may be recommended.
Exactly why this is happening is not known. Overweight and inactivity are key contributing factors. Weight Being overweight is a major risk factor for type 2 diabetes. This is because the more fatty tissue you have, the more resistant your cells become to insulin. The WHO has identified several factors that improve lifestyle to prevent the risk of obesity, such as increasing the intake of fiber-rich dietary fiber, reducing the intake of energy-rich and micronutrient-poor foods, and regular physical activity.
The FINDRISC questionnaire (Finnish diabetes risk score), the most commonly used method 160, is designed to self-assess risk based on seven questions, which has good validity in predicting the future onset of diabetes over a 10-year period. Diabetes treatment involves diet and physical activity, along with lowering blood glucose and levels of other known risk factors that damage blood vessels. Studies have shown that a low-fiber diet with a high glycemic index is positively associated with an increased risk of type 2 diabetes 49, and specific dietary fatty acids can affect insulin resistance and diabetes risk to varying degrees 50. Hyperglycemia, or increased blood sugar, is a common effect of uncontrolled diabetes and, over time, causes serious damage to many of the body's systems, especially nerves and blood vessels. Epidemiological studies have suggested that the risk of diabetes may increase or decrease due to dietary factors.
In addition, vitamin D supplementation is recognized as a promising and cost-effective treatment, which can reduce the risk of type 2 diabetes and improve glycemic parameters in patients with type 2 diabetes. A range of cost-effective interventions can improve patient outcomes, regardless of the type of diabetes they have. The identification of new diabetes genes using GWAS is always a laborious and time-consuming project, requiring many cases for sufficient statistical power to guarantee a very modest increase in the risk of each risk allele. For people with prediabetes, metformin (Fortamet, Glumetza, others), a diabetes medication, may be prescribed to reduce the risk of type 2 diabetes. Metformin has been shown to be effective in lowering blood glucose, increasing insulin sensitivity, reducing cardiovascular risk 92 and the risk of hypoglycemia 93, and is the only hypoglycemic agent that improves macrovascular outcomes 94 and reduces mortality rates in patients with type 2 diabetes.
Type 1 diabetes, formerly known as juvenile diabetes or insulin-dependent diabetes, is a chronic condition in which the pancreas produces little or no insulin on its own. The main objectives are to present new therapeutic strategies and cost-effective intervention trials for type 2 diabetes. Until recently, this type of diabetes was only seen in adults, but now it also occurs more frequently in children. Type 2 diabetes is a serious and common chronic disease that results from a complex interaction between heredity and the environment together with other risk factors, such as obesity and physical inactivity. Type 2 diabetes is a condition that occurs because of a problem in the way the body regulates and uses sugar as fuel.
